Table 2 Stability data of fructose-based 3-acetyl-2,3-dihydro-1,3,4-oxadiazole (GLB) detected by high performance liquid chromatography (HPLC) method in rat plasma (Mean ± SD, n = 3).

From: Quantitative and qualitative analysis of the novel antitumor 1,3,4-oxadiazole derivative (GLB) and its metabolites using HPLC-UV and UPLC-QTOF-MS

Stability

Actual concentration (μg/mL)

Measured concentration (μg/mL)

Precision (RSD, %)

Accuracy (RE, %)

Light and room temperature for 24 hours

0.025

0.026 ± 0.002

7.52

4.17

 

0.5

0.486 ± 0.027

5.53

−2.79

 

4

3.922 ± 0.055

1.41

−1.94

Post-preparative stability (at 4 °C for 48 hours)

0.025

0.026 ± 0.001

3.63

5.31

 

0.5

0.528±0.007

1.25

5.62

 

4

4.233 ± 0.196

4.64

5.83

Post-preparative stability (at 4 °C for 1 week)

0.025

0.026 ± 0.001

4.19

3.83

 

0.5

0.428 ± 0.010

2.25

−14.4

 

4

3.668 ± 0.219

5.98

−8.30

Freeze-thawing 3 cycles (at −20 °C)

0.025

0.025 ± 0.001

−0.75

2.82

 

0.5

0.467 ± 0.036

−6.51

7.65

 

4

3.732 ± 0.227

−6.71

6.08

Freezing storage stability (at −20 °C for 2 weeks)

0.025

0.027 ± 0.001

4.09

8.17

 

0.5

0.535 ± 0.009

1.68

7.10

 

4

4.393 ± 0.090

2.04

9.84

Freezing storage stability (at −20 °C for 1 month)

0.025

0.027 ± 0.002

8.29

8.66

 

0.5

0.490 ± 0.015

3.01

1.17

 

4

4.097 ± 0.213

5.19

−2.27

Freezing storage stability (at −20 °C for 3 months)

0.025

0.023 ± 0.002

−7.12

8.04

 

0.5

0.487 ± 0.003

−2.66

−2.04

 

4

3.918 ± 0.063

0.71

1.62